Veltassa Powder, For Suspension
Product Images NDC 53436-010

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Veltassa (NDC 53436-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vifor Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Veltassa 01)

The text appears to be discussing the composition of a polymeric network containing calcium-sorbitol counterion and patiromer anion. It specifies the number of 2-fluoro-2-propenoate groups and crosslinking groups present in the network. The symbol "*" indicates that the network is extended.*

FDA Label Image

Figure 2 (Veltassa 02)

This appears to be a table of pharmacokinetic parameters, including the geometric mean ratio and 90% confidence intervals for various drugs compared to a reference drug. The table includes information on the AUC and Cmax for each drug.*

FDA Label Image

Figure 3 (Veltassa 03)

Mean serum potassium levels were recorded at different time points during a study visit. The values obtained were 60, 55, 50, and "a5". The baseline serum potassium level was between 5.1 to 5.5 mEq/L, whereas the baseline value for serum K' was between 6.5 to 6.6 mEq/L. No other information or context is available to provide any further description.*

FDA Label Image

Figure 4 (Veltassa 04)

FDA Label Image

Principal Display Panel (8.4 g Packet Carton)

Veltassa is an oral suspension medication used to treat high levels of potassium in the blood. Each packet contains 8.4 grams* of patiromer and is dispensed as a 30 pack supply with 1 scoop per day. The medication should be used within three months of opening and should be kept in a dry place at room temperature or in the fridge. The medication should be mixed with water and taken immediately as directed by a physician. It should be stored out of reach of children. *Equivalent to a nominal amount of 16.8 grams of patiromer powder to be used as directed by a physician. See prescribing information for more details.*

FDA Label Image

Principal Display Panel (16.8 g Packet Carton)

FDA Label Image

Principal Display Panel (25.2 g Packet Carton)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.